Companies / Agile Therapeutics Inc
Agile Therapeutics Inc
AGRXCIK 1261249
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Oct 13, 2021 | Perceptive Advisors LLC 10% owner | Buy Open-market buy | Common Stock | $4.87M | +5.7M +36.02% | 21,654,485 | high |
| Jan 23, 2015 | Aisling Capital III LP Director | Buy Open-market buy | Common Stock | $4.75M | +812K +37.39% | 2,983,797 | high |
| Jan 23, 2015 | Moorin Jay 10% owner | Buy Open-market buy | Common Stock | $4.75M | +812K +21.05% | 4,668,663 | high |
| Mar 23, 2021 | Reilly Dennis Executive | Buy Open-market buy | Common Stock | $102.5K | +50K +47.03% | 156,306 | medium |
| Jul 27, 2021 | Reilly Dennis Executive | Buy Open-market buy | Common Stock | $54.1K | +50K +28.36% | 226,306 | low |
| Aug 26, 2024 | Altomari Alfred CEO | Other Sold to issuer | Common Stock | $42.8K | -28K -58.90% | 19,624 | low |
| Jul 29, 2021 | Altomari Alfred CEO | Buy Open-market buy | Common Stock | $33.1K | +26K +5.36% | 514,910 | low |
| May 18, 2021 | Altomari Alfred CEO | Buy Open-market buy | Common Stock | $32.2K | +20K +4.27% | 488,710 | low |